Other OTC • Healthcare • Medical - Pharmaceuticals • US • USD
Decision Diagnostics Corp. (DECN) has an overall financial health rating of D+ with a composite score of 0 out of 5.
This suggests the company faces some financial challenges worth monitoring. Rating as of 2024-07-26.
Be the first to know when stocks drop below their intrinsic value.
